Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
about
The role of prostaglandins in allergic lung inflammation and asthmaDrug discovery alliances in India--indications, targets, and new chemical entities.Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids.Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.Synthesis of sulfonamides via copper-catalyzed oxidative C-N bond cleavage of tertiary amines.
P2860
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Discovery of potent, selective ...... llergic inflammatory diseases.
@en
Discovery of potent, selective ...... llergic inflammatory diseases.
@nl
type
label
Discovery of potent, selective ...... llergic inflammatory diseases.
@en
Discovery of potent, selective ...... llergic inflammatory diseases.
@nl
prefLabel
Discovery of potent, selective ...... llergic inflammatory diseases.
@en
Discovery of potent, selective ...... llergic inflammatory diseases.
@nl
P2093
P50
P356
P1476
Discovery of potent, selective ...... llergic inflammatory diseases.
@en
P2093
Adeline Prêtre
Catherine Jorand-Lebrun
Christophe Cleva
Delphine Rivron
Fabienne Burgat-Charvillon
Gaële Fraboulet
Hamina Daff
Jean-François Arrighi
Jeyaprakashnarayanan Seenisamy
Manfred Schneider
P304
P356
10.1021/JM200866Y
P407
P577
2011-10-03T00:00:00Z